SL Science Holding Ltd SEC filings SLBT
SL Science Holding Ltd has 42 filings in SEC EDGAR's recent list, going back to Jun 13, 2025. Its latest annual report, Form 20-F, was filed on Jun 18, 2026 for the period ended Jun 12, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 9, 2026 | — |
| 424B3 | Prospectus | Aug 14, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Jul 31, 2026 | — |
| 424B3 | Prospectus | Jan 13, 2026 | — |
| F-4/A | Registration statement | Jan 7, 2026 | — |
| F-4 | Registration statement | Dec 18, 2025 | — |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLBT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Taipei City
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2070534
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.